CIK 0001824893 · Non-accelerated filer<br>Smaller reporting company
Surrozen, Inc./DE
Sign in to watch- Ticker
- SRZN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 301374889
- Phone
- 650-475-2820
- Business address
- 171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Consonance-HFW Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | Li Yang Exec. Vice President, Research | Gift | −1,666 | 14,425 | ||
| 2026-03-24 | TCG Crossover GP II, LLC 10% owner | Purchase | +53,329 | $24.69 | $1.3M | 736,554 |
| 2026-03-24 | TCG Crossover GP II, LLC 10% owner | Purchase | +53,329 | $24.69 | $1.3M | 736,547 |
| 2026-03-23 | TCG Crossover GP II, LLC 10% owner | Purchase | +7,612 | $24.90 | $190K | 683,225 |
| 2026-03-23 | TCG Crossover GP II, LLC 10% owner | Purchase | +7,611 | $24.90 | $190K | 683,218 |
| 2026-03-16 | TCG Crossover GP II, LLC 10% owner | Purchase | +595 | $24.99 | $15K | 675,613 |
| 2026-03-16 | TCG Crossover GP II, LLC 10% owner | Purchase | +595 | $24.99 | $15K | 675,610 |
| 2026-03-13 | TCG Crossover GP II, LLC 10% owner | Purchase | +17,717 | $24.88 | $441K | 675,018 |
| 2026-03-13 | TCG Crossover GP II, LLC 10% owner | Purchase | +17,716 | $24.88 | $441K | 675,015 |
| 2026-03-12 | TCG Crossover GP II, LLC 10% owner | Purchase | +6,187 | $24.99 | $155K | 657,301 |
| 2026-03-12 | TCG Crossover GP II, LLC 10% owner | Purchase | +6,187 | $24.99 | $155K | 657,299 |
| 2026-02-17 | Li Yang Exec. Vice President, Research | Grant or award · Employee Stock Option (right to buy) | +100,950 | 100,950 | ||
| 2026-02-17 | Li Yang Exec. Vice President, Research | Grant or award · Restricted Stock Unit | +100,950 | 100,950 | ||
| 2026-02-17 | Williams Charles O Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +102,900 | 102,900 | ||
| 2026-02-17 | Williams Charles O Chief Operating Officer | Grant or award · Restricted Stock Unit | +102,900 | 102,900 | ||
| 2026-02-17 | Parker Craig C Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +242,200 | 242,200 | ||
| 2026-02-17 | Parker Craig C Chief Executive Officer | Grant or award · Restricted Stock Unit | +242,200 | 242,200 | ||
| 2026-02-12 | TCG Crossover GP II, LLC 10% owner | Purchase | +547 | $23.86 | $13K | 651,114 |
| 2026-02-12 | TCG Crossover GP II, LLC 10% owner | Purchase | +546 | $23.86 | $13K | 651,112 |
| 2026-02-11 | TCG Crossover GP II, LLC 10% owner | Purchase | +8,882 | $23.58 | $209K | 650,567 |
Page 3 of 12 · 237 trades